Mesothelioma Clinical Trials

There are several different Mesothelioma Clinical Trials in progress right now. Below you will find all the active trial information:

 
PHRASE III - ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

PHASE III - Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma

PHASE III - Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

PHASE II - ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

PHASE II - Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

PHASE II - Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma

PHASE II - Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

PHASE II - PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

PHASE II - Pemetrexed Disodium and Gemcitabine in Treating Patients With Malignant Mesothelioma

PHASE II - Alanosine in Treating Patients With Cancer

For a list of more Mesothelioma Clinical Trials in progress click here.